RVMD: Revolution Medicines Inc. Stocks News on November 21, 2024

$Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer$

RVMD

GlobeNewswire

4 months ago

Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer

RVMD

Zacks

4 months ago

Revolution Medicines (RVMD) Moves 11.0% Higher: Will This Strength Last?

Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024

RVMD

GlobeNewswire

4 months ago

Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024

RVMD

MT Newswires

4 months ago

Jefferies Initiates Revolution Medicines at Buy With $63 Price Target

RVMD

GuruFocus.com

5 months ago

Insider Sale: COO Margaret Horn Sells Shares of Revolution Medicines Inc (RVMD)

RVMD

MT Newswires

5 months ago

Revolution Medicines Insider Sold Shares Worth $446,770, According to a Recent SEC Filing

RVMD

Simply Wall St.

5 months ago

Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable

RVMD

MT Newswires

6 months ago

Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

RVMD

GlobeNewswire

6 months ago

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...

RVMD

GuruFocus.com

6 months ago

Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...

Revolution Medicines First Quarter 2024 Earnings: US$0.70 loss per share (vs US$0.72 loss in 1Q 2023)

RVMD

Simply Wall St.

6 months ago

Revolution Medicines First Quarter 2024 Earnings: US$0.70 loss per share (vs US$0.72 loss in 1Q 2023)

RVMD

Insider Monkey

6 months ago

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript

RVMD

MT Newswires

6 months ago

Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating

RVMD

GuruFocus.com

6 months ago

Revolution Medicines Inc (RVMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...

RVMD

MT Newswires

6 months ago

Revolution Medicines Q1 Net Loss Narrows

Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

RVMD

GlobeNewswire

6 months ago

Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

RVMD

GuruFocus.com

7 months ago

Insider Sale: CFO Jack Anders Sells 10,000 Shares of Revolution Medicines Inc (RVMD)

Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

RVMD

GlobeNewswire

7 months ago

Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMD

GlobeNewswire

7 months ago

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMD

GlobeNewswire

7 months ago

Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMD

GlobeNewswire

8 months ago

Revolution Medicines to Participate in Upcoming Investor Conferences

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

RVMD

GlobeNewswire

8 months ago

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

RVMD

Insider Monkey

9 months ago

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript

Revolution Medicines Full Year 2023 Earnings: Misses Expectations

RVMD

Simply Wall St.

9 months ago

Revolution Medicines Full Year 2023 Earnings: Misses Expectations

RVMD

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Revolution Medicines Inc Earnings Call

RVMD

Zacks

9 months ago

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates

RVMD

GuruFocus.com

9 months ago

Revolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical Progress

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

RVMD

GlobeNewswire

9 months ago

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

RVMD

GlobeNewswire

9 months ago

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

RVMD

GlobeNewswire

10 months ago

Revolution Medicines to Participate in Upcoming Investor Conferences

Crocs, Inc. Announces Conference Call to Review Fourth Quarter 2023 Earnings Results

RVMD

PR Newswire

10 months ago

Crocs, Inc. Announces Conference Call to Review Fourth Quarter 2023 Earnings Results

Ryder Completes Acquisition of Cardinal Logistics

RVMD

Business Wire

10 months ago

Ryder Completes Acquisition of Cardinal Logistics

RVMD

Argus Research

10 months ago

Analyst Report: Zions Bancorporation N.A

RVMD

Argus Research

10 months ago

Market Digest: NVO, ADP, MSFT, ROP, SWKS, WY, ZION, MA

RVMD

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Unum Group Earnings Call

Unum Group (UNM) Q4 2023 Earnings Call Transcript

RVMD

Motley Fool

10 months ago

Unum Group (UNM) Q4 2023 Earnings Call Transcript

BJ's Wholesale (BJ) Rides on Membership Surge & Digital Drive

RVMD

Zacks

10 months ago

BJ's Wholesale (BJ) Rides on Membership Surge & Digital Drive

Division CEO A Anderson Sells Shares of Zions Bancorp NA

RVMD

GuruFocus.com

10 months ago

Division CEO A Anderson Sells Shares of Zions Bancorp NA

Allison Transmission (ALSN) Ascends While Market Falls: Some Facts to Note

RVMD

Zacks

10 months ago

Allison Transmission (ALSN) Ascends While Market Falls: Some Facts to Note

RVMD

Insider Monkey

10 months ago

12 Stocks to Buy at a Discount Now

HR Software Q3 Earnings: Paycor (NASDAQ:PYCR) Simply the Best

RVMD

StockStory

10 months ago

HR Software Q3 Earnings: Paycor (NASDAQ:PYCR) Simply the Best

RVMD

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Invesco Ltd Earnings Call

Invesco Canada announces cash distributions for its ETFs

RVMD

CNW Group

10 months ago

Invesco Canada announces cash distributions for its ETFs

MakeMyTrip (MMYT) Tops Q3 Earnings and Revenue Estimates

RVMD

Zacks

10 months ago

MakeMyTrip (MMYT) Tops Q3 Earnings and Revenue Estimates

Invesco Reports Results for the Three Months and Year Ended December 31, 2023

RVMD

PR Newswire

10 months ago

Invesco Reports Results for the Three Months and Year Ended December 31, 2023

New York Times (NYSE:NYT) shareholders have earned a 14% CAGR over the last five years

RVMD

Simply Wall St.

10 months ago

New York Times (NYSE:NYT) shareholders have earned a 14% CAGR over the last five years

Annaly Capital Management Inc (NLY) is Attracting Investor Attention: Here is What You Should Know

RVMD

Zacks

10 months ago

Annaly Capital Management Inc (NLY) is Attracting Investor Attention: Here is What You Should Know

Annaly Capital Management, Inc. Announces Dates of Fourth Quarter 2023 Financial Results and Conference Call

RVMD

Business Wire

10 months ago

Annaly Capital Management, Inc. Announces Dates of Fourth Quarter 2023 Financial Results and Conference Call

RVMD

Zacks

10 months ago

Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High?

Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now

RVMD

Zacks

10 months ago

Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now

Winners And Losers Of Q3: Flowers Foods (NYSE:FLO) Vs The Rest Of The Packaged Food Stocks

RVMD

StockStory

10 months ago

Winners And Losers Of Q3: Flowers Foods (NYSE:FLO) Vs The Rest Of The Packaged Food Stocks

Core & Main Completes Acquisition of Lee Supply Company Inc.

RVMD

Business Wire

10 months ago

Core & Main Completes Acquisition of Lee Supply Company Inc.

The AZEK® Company Inc. Announces Fiscal First Quarter 2024 Earnings Release and Investor Conference Call on February 6, 2024

RVMD

Business Wire

10 months ago

The AZEK® Company Inc. Announces Fiscal First Quarter 2024 Earnings Release and Investor Conference Call on February 6, 2024

Will Monday.com (MNDY) Beat Estimates Again in Its Next Earnings Report?

RVMD

Zacks

10 months ago

Will Monday.com (MNDY) Beat Estimates Again in Its Next Earnings Report?

Flowers Foods (FLO) Shows Solid Resilience Amid Complexities

RVMD

Zacks

10 months ago

Flowers Foods (FLO) Shows Solid Resilience Amid Complexities

Norwegian Cruise Line (NCLH) Falls More Steeply Than Broader Market: What Investors Need to Know

RVMD

Zacks

10 months ago

Norwegian Cruise Line (NCLH) Falls More Steeply Than Broader Market: What Investors Need to Know

The Chesapeake-Southwestern Deal Creates a New Giant for Natural-Gas Exports

RVMD

The Wall Street Journal

10 months ago

The Chesapeake-Southwestern Deal Creates a New Giant for Natural-Gas Exports

Core & Main (CNM) Recently Broke Out Above the 20-Day Moving Average

RVMD

Zacks

10 months ago

Core & Main (CNM) Recently Broke Out Above the 20-Day Moving Average

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?

RVMD

Zacks

10 months ago

Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?

Carnival upgraded, PayPal downgraded: Wall Street's top analyst calls

RVMD

The Fly

a year ago

Carnival upgraded, PayPal downgraded: Wall Street's top analyst calls

Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference

RVMD

GlobeNewswire

a year ago

Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference

Brookfield Renewable to Host Fourth Quarter 2023 Results Conference Call

RVMD

GlobeNewswire

a year ago

Latest Revolution Medicines Inc. (RVMD) News on November 21, 2024

Share on Social Networks: